Home › Bicuspid Aortic Valve Disease › NCT03836521
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
RecruitingObservational study
The International Multicenter Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
Who can join
Ages 19 to 129 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Age≥18 years. 2. Severe aortic stenosis with bicuspid anatomy. 3. NYHA≥2 and/or syncope and/or angina. 4. Patient judged by the Heart Team as indicated for TAVR. Exclusion Criteria: 1. Age \<18 years 2. Asymptomatic patients 3. Pure aortic regurgitation.
About the study
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
What is being tested
- Transcatheter aortic valve replacement (device)
Sponsor: Cedars-Sinai Medical Center · Participants: 2,000 · Started: Aug 15, 2016
Contact the study team
- Sung-Han Yoon, M.D. · Phone: 3104237426
Official record on ClinicalTrials.gov — NCT03836521
Locations in the U.S.
| California | Cedars-Sinai Medical Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.